WellDoc®, a leading digital therapeutic company, announces today the formation of its scientific advisory team whose expertise spans cardiology, health behavior, endocrinology, primary care and pharmacy-based diabetes education and care. Richard Katz, MD, Janet Duni, RN, BSN, MPA, CCM, Pablo Mora, MD, Nancy D’Hondt, RPh, CDE, FAADE, Edwin Fisher, PhD and Charlene Quinn, PhD have each been involved in WellDoc’s digital health journey with product enhancement, evaluation, or implementation and have been asked to now formally serve as scientific advisors to the company.
{iframe}https://www.welldoc.com/images/uploads/science-advisors.pdf{/iframe}